La Agencia Europea de Medicamentos (EMA) emitió ayer un dictamen favorable sobre dos tratamientos contra la covid-19 —Ronapreve y Regkirona— que la Comisión Europea ha considerado opciones te...
Read moreThe manuscript, entitled "Comprehensive in Vitro Characterization of the LSD1 Small Molecule Inhibitor Class in Oncology”, compares iadademstat with four LSD1 inhibitors in clinical development in o...
Read moreThe joint work of the healthcare and research team, together with a precise diagnosis from the molecular biology laboratory and the surgical team's work made it possible to treat a patient who had run...
Read moreAs the report in Farmaindustria magazine indicates, incremental innovation in medicines is a growing need, both for patients and healthcare professionals. This has the essential purpose of facilitatin...
Read moreThe biotechnological pharmaceutical company HIPRA has received authorization from the Spanish Agencyfor Medicines and Health Products (AEMPS) to start Phase IIb of the clinical trial of the HIPRA vac...
Read moreUn equipo científico estadounidense ha detectado a la segunda persona seropositiva que no presenta ninguna evidencia de genomas intactos del VIH tras analizar más de 1.500 millones de células de sa...
Read moreEl acceso gratuito a nuevos medicamentos ha tenido un impacto muy favorable, según un estudio
Read moreEl microbiólogo del CNB-CSIC estudia las mutaciones que confieren a las bacterias la capacidad de resistir a los fármacos y subraya la necesidad del diagnóstico precoz
Read moreBiopsies obtained by flexible bronchoscopy have been used to analyze which patients have sequelae in the lung in order to recommend, if necessary, the administration of corticosteroids as a treatment....
Read moreUn estudio de investigadores del Hospital del Mar, del Instituto Hospital del Mar de Investigaciones Médicas y del Hospital Son Espases, demuestra que la combinación de un nuevo antibiótico, la cef...
Read moreVifor Pharma and Sanifit Therapeutics, a clinical-stage cardio-renal biopharmaceutical company focused on treatments for progressive vascular calcification disorders, today announced the companies hav...
Read moreLa primera aproximación de terapia génica para tratar la leucoencefalopatía megalencefálica con quistes subcorticales (MLC) ha sido designada como medicamento huérfano por la Agencia Europea del ...
Read more